Bnp Paribas Arbitrage, Snc »

Inhibrx Biosciences shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 1.1k 14.17

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
iShares Russell 2000 ETF Fund (IWM)
Tesla Equity (TSLA)
Visa Equity (V)
Alphabet Equity (GOOGL)
Broadcom Equity (AVGO)
Alphabet Equity (GOOG)
SPDR S&P 500 ETF Trust Fund (SPY)
Costco Wholesale Corp Equity (COST)
Exxon Mobil Corp Equity (XOM)
Industrial Select Sector SPDR Fund Fund (XLI)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences